HC Wainwright & Co. Reiterates Buy on Biophytis, Maintains $15 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Biophytis (NASDAQ:BPTS) and maintained a $15 price target.
August 16, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biophytis has received a reiterated 'Buy' rating from HC Wainwright & Co. with a maintained price target of $15.
The reiterated 'Buy' rating and maintained price target by HC Wainwright & Co. indicates their continued confidence in Biophytis. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100